Novelion Therapeutics Inc (NASDAQ:NVLN)

4.07
Delayed Data
As of May 25
 -0.31 / -7.08%
Today’s Change
3.08
Today|||52-Week Range
10.68
+30.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$76.5M

Company Description

Novelion Therapeutics, Inc. develops and markets ocular products. It is engaged in developing new standards of care for individuals living with rare diseases. The company is headquartered in Vancouver, Canada.

Contact Information

Novelion Therapeutics, Inc.
510 West Georgia Street
Vancouver British Columbia V6B 0M3
P:(617) 500-7867
Investor Relations:

Employees

Shareholders

Other institutional71.44%
Individual stakeholders13.93%
Mutual fund holders10.55%

Top Executives

Jeffrey HackmanChief Operating Officer & Executive VP
Michael Dennis PriceChief Financial Officer & Senior Vice President
Murray StewartExecutive VP, Head-Research & Development
Roger W. LouisChief Compliance Officer
Linda BuonoSenior Vice President-Human Resources